Kidney transplantation using complement inhibitor in a patient suffering from atypical hemolytic-uremic syndrome associated with factor H antibodies: successful prevention of recurrence of the underlying disease

Atypical hemolytic-uremic syndrome (aHUS) is an extremely rare complement-mediated disease that belongs to the group of thrombotic microangiopathies (TMA). It often reoccurs after kidney transplantation (KT). Previously, KT was considered contraindicated in both children and adults with aHUS due to...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς: E. I. Prokopenko, S. A. Pasov, A. V. Vatazin, A. Ya. Tsalman, T. E. Pankratenko, G. A. Generalova
Μορφή: Artigo
Γλώσσα:Russo
Έκδοση: Federal Research Center of Transplantology and Artificial Organs named after V.I.Shumakov 2020-07-01
Σειρά:Vestnik Transplantologii i Iskusstvennyh Organov
Θέματα:
atypical hemolytic-uremic syndrome
eculizumab
kidney transplantation
complement-activating conditions
Διαθέσιμο Online:https://journal.transpl.ru/vtio/article/view/1194
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια